Intestinal lavage fluid picoprep(R)formulation Internal use group only Picosulfate sodium internal solution 0.75% in combination with the oral administration group Validation on intestinal washing degree

Intestinal lavage fluid picoprep(R)formulation Internal use group only Picosulfate sodium internal solution 0.75% in combination with the oral administration group Validation on intestinal washing degree - Comparison between picoprep (R) alone oral administration group and oral administration strengthening group

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033105

Enrollment

100

Registered

2018-06-26

Start date

2018-06-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Compare single oral administration group of picoprep (R) and oral administration strengthening group

Interventions

Picosulfate sodium 0.75% 5 ml oral administration Picosulfate sodium 0.75% 5 ml non-oral dosage

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients who need colonoscopy (2) Patients whose age ranges from 20 to 80 (3) Patients who explained and understood the outline of this research and obtained written informed consent

Exclusion criteria

Exclusion criteria: (1) Patients who have undergone colon surgery (excluding appendectomy, hemorrhoid surgery, past endoscopic procedures) (2) Patients with colon lesions for preoperative examination purposes or for endoscopic treatment purposes (3) Patients with inflammatory bowel disease (4) Patients with uncontrolled angina, myocardial infarction within the past 3 months, congestive heart failure or uncontrolled hypertension (5) Patients who allergy of PIcoprep and Picosulfate sodium. (6) Patients who are not suitable to this study.

Design outcomes

Primary

Measure	Time frame
Intestinal washing degree(using Ottawa scale)	—

Secondary

Measure	Time frame
Pretreatment time, presence or absence of addition of pretreatment, endoscope insertion time, endoscopic observation time, endoscope insertion rate, presence or absence of complications accompanying intestinal wash fluid administration, Adenoma detection rate (ADR), polyp detection rate (PDR ), mean number of adenomas per patients (MAP), patient acceptance	—

Countries

Japan

Contacts

Public ContactTerasawa Masaaki

Fukuoka University Chikushi Hospital Gastroenterology

masaakiterasawa@gmail.com092-921-1011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026